Laurie M. Strawn

1.4k total citations
12 papers, 1.2k citations indexed

About

Laurie M. Strawn is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Laurie M. Strawn has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Laurie M. Strawn's work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Laurie M. Strawn is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Laurie M. Strawn collaborates with scholars based in United States, Japan and Germany. Laurie M. Strawn's co-authors include Laura K. Shawver, Julie M. Cherrington, Axel Ullrich, B Millauer, Werner Risau, Karl H. Plate, Gerald McMahon, T. Annie T. Fong, Peter Vajkoczy and Axel Ullrich and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Drug Discovery Today.

In The Last Decade

Laurie M. Strawn

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurie M. Strawn United States	9	899	394	369	124	91	12	1.2k
T. Annie T. Fong United States	7	1.3k 1.4×	523 1.3×	555 1.5×	231 1.9×	120 1.3×	10	1.8k
Yoshihiro Mitsuhashi Japan	10	866 1.0×	455 1.2×	409 1.1×	130 1.0×	82 0.9×	11	1.2k
Tim P. Green United Kingdom	13	699 0.8×	504 1.3×	133 0.4×	159 1.3×	92 1.0×	14	1.2k
Efstathia Giannopoulou Greece	20	561 0.6×	297 0.8×	277 0.8×	129 1.0×	88 1.0×	44	1.0k
Wells S. Brown United States	15	552 0.6×	266 0.7×	206 0.6×	139 1.1×	67 0.7×	24	895
Esther Bridges United Kingdom	21	1.1k 1.3×	430 1.1×	744 2.0×	130 1.0×	58 0.6×	38	1.7k
Mike F. Burbridge France	19	567 0.6×	250 0.6×	178 0.5×	112 0.9×	55 0.6×	33	970
Anna L. Stratford Canada	24	1.2k 1.4×	567 1.4×	445 1.2×	130 1.0×	44 0.5×	27	1.9k
Kenneth R. LaMontagne United States	14	751 0.8×	273 0.7×	149 0.4×	60 0.5×	83 0.9×	21	1.1k
Alastair J. King United States	18	1.6k 1.8×	659 1.7×	149 0.4×	134 1.1×	104 1.1×	28	2.0k

Countries citing papers authored by Laurie M. Strawn

Since Specialization

Citations

This map shows the geographic impact of Laurie M. Strawn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie M. Strawn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie M. Strawn more than expected).

Fields of papers citing papers by Laurie M. Strawn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie M. Strawn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie M. Strawn. The network helps show where Laurie M. Strawn may publish in the future.

Co-authorship network of co-authors of Laurie M. Strawn

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie M. Strawn. A scholar is included among the top collaborators of Laurie M. Strawn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie M. Strawn. Laurie M. Strawn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dagher, Ramzi, et al.. (2015). The Relationship Between Development Start Lag and Approval Lag in Oncology Drug Development in Japan. Therapeutic Innovation & Regulatory Science. 49(6). 911–919. 10 indexed citations

Chiba, Kōji, et al.. (2012). Potential factors correlating to the PMDA’s decision to waive Japanese Phase 2 and 3 studies for oncology drugs New Drug Application in Japan. Investigational New Drugs. 31(4). 1051–1055. 1 indexed citations

Strawn, Laurie M., et al.. (2000). Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.. PubMed. 6(7). 2931–40. 17 indexed citations

Cherrington, Julie M., Laurie M. Strawn, & Laura K. Shawver. (2000). New paradigms for the treatment of cancer: The role of anti-angiogenesis agents. Advances in cancer research. 79. 1–38. 158 indexed citations

Laird, Alexander, Peter Vajkoczy, Laura K. Shawver, et al.. (2000). SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.. PubMed. 60(15). 4152–60. 402 indexed citations

Strawn, Laurie M. & Laura K. Shawver. (1998). Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials. Expert Opinion on Investigational Drugs. 7(4). 553–573. 57 indexed citations

Shawver, Laura K., Kenneth E. Lipson, T. Annie T. Fong, et al.. (1997). Receptor tyrosine kinases as targets for inhibition of angiogenesis. Drug Discovery Today. 2(2). 50–63. 64 indexed citations

Millauer, B, et al.. (1996). Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.. PubMed. 56(7). 1615–20. 354 indexed citations

Shawver, Laura K., Laurie M. Strawn, & Axel Ullrich. (1995). Membrane bound receptor tyrosine kinases and chemical carcinogenesis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 333(1-2). 23–28. 5 indexed citations

10.

Strawn, Laurie M., E Mann, Lucie Germain, et al.. (1994). Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor.. Journal of Biological Chemistry. 269(33). 21215–21222. 98 indexed citations

11.

Strawn, Laurie M., Robert E. Martell, Robert U. Simpson, Karen L. Leach, & Raymond E. Counsell. (1989). Iodoaryl analogs of dioctanoylglycerol and 1-oleoyl-2-acetylglycerol as probes for protein kinase C. Journal of Medicinal Chemistry. 32(9). 2104–2110. 10 indexed citations

12.

Strawn, Laurie M., Robert E. Martell, Robert U. Simpson, Karen L. Leach, & Raymond E. Counsell. (1989). Synthesis and evaluation of iodinated analogs of diacylglycerols as potential probes for protein kinase C. Journal of Medicinal Chemistry. 32(3). 643–648. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact